We use cookies on this website. By continuing to use this site without changing your cookie settings, you agree that you are happy to accept our cookies and for us to access these on your device. Find out more about how we use cookies and how to change your cookie settings.

Executive Board

Our day-to-day activities are managed by the Director of the Wellcome Trust and an Executive Board of senior managers drawn from the different divisions of the organisation.


Jeremy Farrar (Director of the Wellcome Trust)
Jeremy Farrar became Director of the Wellcome Trust in October 2013. Before joining the Trust he was Director of the Oxford University Clinical Research Unit in Vietnam, where his research interests were infectious diseases, tropical health and emerging infections. He has contributed to 500 peer-reviewed scientific papers and served on several World Health Organization advisory committees.

Jeremy was appointed OBE in 2005 for services to Tropical Medicine. He was awarded the Memorial Medal and Ho Chi Minh City Medal from the Government of Vietnam, Frederick Murgatroyd Prize for Tropical Medicine by the Royal College Physicians and the Bailey Ashford Award by the American Society for Tropical Medicine and Hygiene. He is a Fellow of the Academy of Medical Sciences, and chairs the International Severe Acute Respiratory and Emerging Infection Consortium, a global initiative to share data about emerging diseases that could become epidemics or pandemics.



Ted Bianco (Director - Technology Transfer)
Ted Bianco joined the Trust in 1999 as Head of Centres and Initiatives in the Science Funding division. With the aid of a multidisciplinary team drawn from science, business and law, he founded the division of Technology Transfer in 2003 with the primary goal of translating basic research into health products and public health tools in areas of unmet medical need. Before joining the Trust, Ted was the Walter Myers Professor of Parasitology at the Liverpool School of Tropical Medicine and worked previously at Imperial College, London, the Walter and Eliza Hall Institute in Melbourne and the London School of Hygiene and Tropical Medicine, specialising in infectious diseases.



John Cooper (Francis Crick Institute Chief Operating Officer and Deputy Chief Executive Officer)
John Cooper is Chief Operating Officer and Deputy CEO of the Francis Crick Institute. John joined the Crick Institute in the summer of 2009. He was previously Director of Resources of the Wellcome Trust, where he was responsible for a wide range of business services, including various construction and other large projects. He is also Managing Director of the Wellcome Trust Genome Campus at Hinxton and a Director of Stevenage Bioscience Catalyst (a joint venture between the Wellcome Trust and GlaxoSmithKline with support from the Department for Business, Innovation and Skills, and the East of England Development Agency). Before joining the Wellcome Trust in 1999, John spent 30 years in the commercial electronics industry.



Simon Jeffreys (Chief Operating Officer)
Simon Jeffreys joined the Trust in March 2009. He is responsible for a wide range of business services, including finance, human resources, information technology, legal, facilities management, grants management, risk management and internal audit.

Simon was previously Chief Administrative Officer for Fidelity International and for most of his professional life was a partner in PricewaterhouseCoopers, where he was the global leader of the firm's investment management and real estate practice.

Simon is a non-executive director and chairs the audit committees for Aon UK Ltd, Henderson International Investment Trust and SimCorp A/S.Simon represents the Trust on the Boards of Syncona, Genome Research Limited, Hilleman Laboratories and Diamond Light Source Limited.



David Lynn (Director - Strategic Planning and Policy)
David joined the Wellcome Trust in April 2004, where he is a member of the Executive Team and the Director of Strategic Planning and Policy. His responsibilities include leading the Trust's strategic planning, policy and evaluation functions.

David's career has been in science policy and strategy. He has worked alongside the UK's Chief Scientific Adviser in the Cabinet Office. His time at the UK Department of Trade and Industry involved him working closely with the European Space Agency and European Commission on earth observation policy; and he has worked in a number of roles for the Natural Environment Research Council.

David is a member of BBC's independent Appeals Advisory Committee; Governing Body and Executive Committee of the Public Health Foundation of India; UK Association of Medical Research Charities Executive Council; and the European Foundation Centre's Research Forum.



Clare Matterson (Director - Medical Humanities and Engagement)
Clare Matterson has responsibility for medical humanities, public engagement, education, media and communications, the Wellcome Library and Wellcome Collection - the free destination for the incurably curious.Clare led the Wellcome Trust's plans to establish the National Science Learning Centre - a major initiative with the UK Government to drive improvement in science education.

Clare joined the Trust in 1999 as Head of Policy, and produced the Trust's first Strategic Plan. Prior to her time at the Trust, Clare worked as a Management Consultant with PricewaterhouseCoopers (PwC), advising universities, government departments and funding councils in the UK and overseas. She was a Senior Policy Adviser to the 1999 National Committee of Enquiry into Higher Education and has also worked for the Higher Education Funding Council and the Higher Education Quality Council. She spent two years at the State University of New York, following receipt of a Fulbright Fellowship.


Kevin Moses (Director - Science Funding)
Kevin Moses joined the Trust in July 2011. Kevin was the founding Chief Academic Officer at the Howard Hughes Medical Institute's Janelia Farm Research Campus. Previously, he held faculty positions at Emory University and the University of Southern California, where he led a research group that studied morphogenetic mechanisms in the development of the Drosophila compound eye.



Danny Truell (Chief Investment Officer)
Danny Truell joined the Trust in 2005, having previously been a Managing Director of Goldman Sachs and Co. in its investment management division. Prior to joining Goldman Sachs in 1996, Danny's career was focused on Asian financial markets.


Susan J Wallcraft (General Counsel and Company Secretary)
Susan Wallcraft joined the Trust in July 2012 and is responsible for the leadership of the Legal Department.Susan has over 15 years' experience advising organisations in the Life Sciences field and prior to joining the Trust was Assistant General Counsel at Pfizer Inc. where she led the Legal team that supported the Primary Care Business Unit in Europe, Canada, Australia and New Zealand.

Wellcome Trust, Gibbs Building, 215 Euston Road, London NW1 2BE, UK T:+44 (0)20 7611 8888